LCI Lannett Company, Inc. Stock Quote

LCI [NYSE]

Healthcare | Drug Manufacturers - Specialty & Generic | USA

Index	-	P/E	-	EPS (ttm)	-7.93	Insider Own	9.20%	Shs Outstand	40.50M	Perf Week	-5.73%
Market Cap	23.49M	Forward P/E	-	EPS next Y	-1.32	Insider Trans	6.19%	Shs Float	37.16M	Perf Month	-24.31%
Income	-316.20M	PEG	-	EPS next Q	-0.46	Inst Own	52.70%	Short Float	15.43%	Perf Quarter	-35.04%
Sales	372.40M	P/S	0.06	EPS this Y	-967.30%	Inst Trans	-12.79%	Short Ratio	20.64	Perf Half Y	-72.14%
Book/sh	-3.93	P/B	-	EPS next Y	14.30%	ROA	-49.80%	Target Price	2.25	Perf Year	-89.09%
Cash/sh	2.29	P/C	0.22	EPS next 5Y	15.00%	ROE	351.10%	52W Range	0.45 - 5.82	Perf YTD	-68.70%
Dividend	-	P/FCF	0.92	EPS past 5Y	-57.50%	ROI	-54.70%	52W High	-91.23%	Beta	1.21
Dividend %	-	Quick Ratio	2.40	Sales past 5Y	-3.30%	Gross Margin	12.90%	52W Low	13.30%	ATR	0.06
Employees	812	Current Ratio	3.40	Sales Q/Q	-30.20%	Oper. Margin	-35.50%	RSI (14)	37.80	Volatility	13.19% 11.75%
Optionable	Yes	Debt/Eq	-	EPS Q/Q	-376.70%	Profit Margin	-84.90%	Rel Volume	0.51	Prev Close	0.51
Shortable	Yes	LT Debt/Eq	-	Earnings	May 04 AMC	Payout	-	Avg Volume	277.88K	Price	0.51
Recom	3.00	SMA20	-10.30%	SMA50	-27.39%	SMA200	-72.21%	Volume	115,117	Change	0.65%

Mar-20-19

Initiated

SunTrust

Hold

Aug-20-18

Downgrade

ROTH Capital

Buy → Neutral

Aug-20-18

Downgrade

Raymond James

Outperform → Mkt Perform

Jan-24-18

Initiated

Goldman

Neutral

Jun-29-16

Initiated

Deutsche Bank

Hold

$26

Mar-24-16

Downgrade

Canaccord Genuity

Buy → Sell

$28 → $18

Feb-04-16

Upgrade

Craig Hallum

Hold → Buy

Nov-05-15

Downgrade

Craig Hallum

Buy → Hold

Sep-03-15

Reiterated

ROTH Capital

Buy

$61 → $68

Jul-21-15

Initiated

Susquehanna

Positive

Feb-05-15

Reiterated

ROTH Capital

Buy

$54 → $61

Nov-24-14

Reiterated

ROTH Capital

Buy

$66 → $60

Nov-04-14

Reiterated

ROTH Capital

Buy

$53 → $66

Nov-04-14

Reiterated

Canaccord Genuity

Buy

$55 → $73

Nov-04-14

Downgrade

Oppenheimer

Outperform → Perform

$53

Oct-13-14

Reiterated

Oppenheimer

Outperform

$51 → $53

Jul-15-14

Reiterated

Oppenheimer

Outperform

$49 → $52

May-06-14

Resumed

Canaccord Genuity

Buy

$55

Feb-10-14

Reiterated

Canaccord Genuity

Buy

$29 → $55

Feb-07-14

Reiterated

Oppenheimer

Outperform

$41 → $45

May-12-22 11:02AM	Lannett Company, Inc.'s (NYSE:LCI) recent US$7.2m market cap decline means a loss of US$272k for insiders who bought this year Simply Wall St.
06:52AM	LANNETT ENTERS AGREEMENT TO BE EXCLUSIVE U.S. DISTRIBUTOR OF FLUDARABINE PHOSPATE FOR INJECTION, USP PR Newswire
May-04-22 07:35PM	Lannett (LCI) Reports Q3 Loss, Lags Revenue Estimates Zacks -5.30%
04:15PM	LANNETT REPORTS FISCAL 2022 THIRD-QUARTER FINANCIAL RESULTS PR Newswire
Apr-27-22 06:52AM	LANNETT TO REPORT FISCAL 2022 THIRD-QUARTER FINANCIAL RESULTS, HOST CONFERENCE CALL ON WEDNESDAY, MAY 4 PR Newswire -5.50%
Mar-29-22 06:52AM	LANNETT INITIATES PIVOTAL CLINICAL TRIAL FOR BIOSIMILAR INSULIN GLARGINE PR Newswire
Mar-18-22 04:15PM	LANNETT ANNOUNCES RECEIPT OF NOTICE OF NON-COMPLIANCE FROM NYSE RELATED TO STOCK PRICE PR Newswire +5.31%
Mar-07-22 12:39PM	Lannett's low stock price leads to NYSE compliance warning American City Business Journals
Mar-04-22 05:33PM	LANNETT TO PRESENT AT THE 34th ANNUAL ROTH CONFERENCE ON MARCH 14 PR Newswire
04:15PM	LANNETT ANNOUNCES RECEIPT OF NOTICE OF NON-COMPLIANCE FROM NYSE PR Newswire
02:34PM	Lab notes: Myonex acquires German drug business; Vallon receives Covid drug treatment patent American City Business Journals
06:52AM	LANNETT Announces sale of liquid drug manufacturing plant and other assets for $10.5 million PR Newswire
Feb-05-22 08:10AM	Lannett Company, Inc. (NYSE:LCI) Analysts Just Trimmed Their Revenue Forecasts By 11% Simply Wall St.
Feb-03-22 06:25PM	Lannett (LCI) Reports Q2 Loss, Misses Revenue Estimates Zacks
04:15PM	LANNETT REPORTS FISCAL 2022 SECOND-QUARTER FINANCIAL RESULTS; REVISES DOWN FULL-YEAR GUIDANCE PR Newswire
Jan-27-22 06:52AM	LANNETT TO REPORT FISCAL 2022 SECOND-QUARTER FINANCIAL RESULTS, HOST CONFERENCE CALL ON THURSDAY, FEBRUARY 3 PR Newswire -6.21%
Jan-26-22 03:01PM	Earnings Preview: Lannett (LCI) Q2 Earnings Expected to Decline Zacks
Jan-21-22 06:52AM	LANNETT ANNOUNCES FDA COMPLETES REVIEW OF INVESTIGATIONAL NEW DRUG (IND) APPLICATION FOR BIOSIMILAR INSULIN GLARGINE PR Newswire -6.45%
Dec-20-21 06:52AM	LANNETT ANNOUNCES SUBMISSION OF INVESTIGATIONAL NEW DRUG (IND) APPLICATION FOR BIOSIMILAR INSULIN GLARGINE PR Newswire
Nov-03-21 07:55PM	Lannett (LCI) Reports Q1 Loss, Tops Revenue Estimates Zacks
07:31PM	Lannett Company, inc (LCI) Q1 2022 Earnings Call Transcript Motley Fool
04:15PM	Lannett Reports Fiscal 2022 First-Quarter Financial Results; Revises Down Full-year Guidance PR Newswire
Oct-28-21 06:52AM	Lannett To Report Fiscal 2022 First-quarter Financial Results, Host Conference Call On Wednesday, November 3 PR Newswire
Oct-27-21 03:03PM	Earnings Preview: Lannett (LCI) Q1 Earnings Expected to Decline Zacks +6.35%
Sep-10-21 09:44AM	4 Penny Stocks Insiders Are Buying Benzinga
Aug-30-21 11:56AM	New Strong Sell Stocks for August 30th Zacks
07:47AM	Is There An Opportunity With Lannett Company, Inc.'s (NYSE:LCI) 30% Undervaluation? Simply Wall St.
06:52AM	Lannett Commences Marketing Mycophenolate Mofetil For Oral Suspension PR Newswire
Aug-26-21 05:00AM	Lannett Company, inc (LCI) Q4 2021 Earnings Call Transcript Motley Fool -7.60%
Aug-25-21 04:15PM	Lannett Announces Fiscal 2021 Fourth-Quarter, Full-Year Financial Results PR Newswire -8.11%
Aug-18-21 06:52AM	Lannett To Report Fiscal 2021 Fourth-quarter, Full-year Financial Results, Host Conference Call On Wednesday, August 25 PR Newswire
Aug-04-21 09:34AM	10 Pharma Companies Making Treatment for Opioid Overdose Insider Monkey
Jul-29-21 06:52AM	LANNETT expands respiratory pipeline, signs exclusive distribution agreement for generic SPIRIVA® handihaler® PR Newswire
Jul-12-21 06:52AM	Lannett Launches Fluvastatin Sodium ER Tablets PR Newswire
Jun-09-21 03:25AM	Lannett (LCI) Soars 10.1%: Is Further Upside Left in the Stock? Zacks
Jun-01-21 06:52AM	Lannett Announces FDA Acceptance, As A Priority Original ANDA, Of The Generic Advair Diskus® Filing PR Newswire
May-28-21 05:39PM	Why Lannett Flopped on Friday Motley Fool -12.96%
May-27-21 05:47PM	Organon Set to Join S&P 500; HollyFrontier to Join S&P MidCap 400; Service Properties Trust to Join S&P SmallCap 600 PR Newswire
May-06-21 01:01AM	Lannett Company, Inc (LCI) Q1 2021 Earnings Call Transcript Motley Fool
May-05-21 08:05PM	Lannett (LCI) Beats Q3 Earnings Estimates Zacks
04:15PM	Lannett Announces Fiscal 2021 Third-Quarter Financial Results PR Newswire
02:30PM	Lannett Co., Inc. to Host Earnings Call ACCESSWIRE
08:37AM	Reflecting on Lannett Company's (NYSE:LCI) Share Price Returns Over The Last Five Years Simply Wall St.
Apr-28-21 12:33PM	Earnings Preview: Lannett (LCI) Q3 Earnings Expected to Decline Zacks
06:53AM	Lannett To Report Fiscal 2021 Third-Quarter Financial Results, Host Conference Call On Wednesday, May 5 PR Newswire
Apr-22-21 04:15PM	Lannett Announces Closing Of $350 Million Senior Secured Notes And $190 Million Second Lien Senior Secured Loan Facility PR Newswire
Apr-09-21 06:52AM	Lannett Announces Pricing Of $350 Million Senior Secured Notes Due 2026 PR Newswire
Apr-06-21 08:12AM	Lannett Company, Inc. -- Moody's rates Lannett's proposed secured notes B1; B3 CFR affirmed Moody's
07:21AM	Lannett Announces Offering Of $350 Million Senior Secured Notes Due 2026 PR Newswire
Apr-01-21 08:30AM	Lannett Submits ANDA For Generic ADVAIR DISKUS® PR Newswire +8.71%
Mar-21-21 09:14PM	SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Lannett Company, Inc. - LCI Newsfile
Mar-18-21 05:25PM	SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Lannett Company, Inc. - LCI PR Newswire
Mar-16-21 09:35PM	SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Lannett Company, Inc. - LCI ACCESSWIRE
Mar-14-21 10:31PM	SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Lannett Company, Inc. - LCI Newsfile
Mar-12-21 06:25AM	SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Lannett Company, Inc. - LCI PR Newswire
Mar-10-21 07:48AM	Lannett plans to file experimental insulin product with FDA sometime this year MarketWatch +9.17%
06:52AM	Lannett Development Of Biosimilar Insulin Glargine Product Continues To Advance PR Newswire
Mar-09-21 10:58PM	SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Lannett Company, Inc. - LCI ACCESSWIRE
Mar-07-21 02:39PM	SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Lannett Company, Inc. - LCI Newsfile
Mar-03-21 03:00AM	SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Lannett Company, Inc. - LCI PR Newswire
Feb-22-21 02:04PM	SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Lannett Company, Inc. - LCI Newsfile
Feb-20-21 06:30PM	SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Lannett Company, Inc. - LCI ACCESSWIRE
Feb-19-21 01:15AM	SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Lannett Company, Inc. - LCI PR Newswire
Feb-15-21 10:16PM	SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Lannett Company, Inc. - LCI Newsfile
Feb-13-21 02:40PM	SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Lannett Company, Inc. - LCI ACCESSWIRE
Feb-11-21 01:35PM	SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Lannett Company, Inc. - LCI Newsfile
Feb-09-21 06:53AM	Lannett Expands Strategic Relationship To Include Biosimilar Fast-Acting Insulin PR Newswire +8.46%
Feb-08-21 07:10PM	SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Lannett Company, Inc. - LCI ACCESSWIRE
06:52AM	Lannett Begins Marketing Chlorpromazine Hydrochloride Tablets PR Newswire
Feb-06-21 11:09PM	SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Lannett Company, Inc. - LCI Newsfile
Feb-04-21 01:33PM	Why Lannett Stock Is Plunging Today Motley Fool -16.04%
Feb-03-21 09:31PM	Lannett Company, Inc (LCI) Q2 2021 Earnings Call Transcript Motley Fool
06:05PM	Lannett (LCI) Meets Q2 Earnings Estimates Zacks
05:39PM	Recap: Lannett Q2 Earnings Benzinga
04:15PM	Lannett Announces Fiscal 2021 Second-Quarter Financial Results In Line Or Above Expectations PR Newswire
02:45PM	Lannett Co., Inc. to Host Earnings Call ACCESSWIRE
Jan-27-21 06:52AM	Lannett To Report Fiscal 2021 Second-Quarter Financial Results, Host Conference Call On Wednesday, February 3 PR Newswire +9.67%
Dec-15-20 10:48AM	Lannett Company, Inc. -- Moody's announces completion of a periodic review of ratings of Lannett Company, Inc. Moody's
Dec-10-20 09:24PM	Is LCI A Good Stock To Buy Now? Insider Monkey
Dec-07-20 05:42PM	Lannett Company, Inc. -- Moody's downgrades Lannett's liquidity rating to SGL-3; ratings affirmed Moody's
04:15PM	Lannett Announces New $30 Million Revolving Credit Facility PR Newswire
Nov-30-20 06:52AM	Lannett Pays Off, In Full, Remaining Term A Loans PR Newswire
Nov-06-20 07:38AM	Earnings Miss: Lannett Company, Inc. Missed EPS And Analysts Are Revising Their Forecasts Simply Wall St.
Nov-04-20 08:31PM	Lannett Inc (LCI) Q1 2021 Earnings Call Transcript Motley Fool
07:55PM	Lannett (LCI) Q1 Earnings and Revenues Lag Estimates Zacks
04:15PM	Lannett Announces Fiscal 2021 First-quarter Financial Results; Affirms Guidance PR Newswire
02:30PM	Lannett Co., Inc. to Host Earnings Call ACCESSWIRE
08:58AM	How Much Did Lannett Company's(NYSE:LCI) Shareholders Earn From Share Price Movements Over The Last Five Years? Simply Wall St.
Nov-03-20 06:52AM	Lannett Launches Authorized Generic of Tirosint® (Levothyroxine Sodium Capsules) PR Newswire
Oct-28-20 12:32PM	Earnings Preview: Lannett (LCI) Q1 Earnings Expected to Decline Zacks
06:53AM	Lannett To Report Fiscal 2021 First-Quarter Financial Results, Host Conference Call On Wednesday, November 4 PR Newswire
Aug-27-20 06:07AM	Why Lannett's Fiscal Q4 Update Disappointed Despite Beating Wall Street Estimates Motley Fool -14.71%
Aug-26-20 08:30PM	Lannett Inc (LCI) Q4 2020 Earnings Call Transcript Motley Fool
05:14PM	Lannett: Q4 Earnings Insights Benzinga
04:15PM	Lannett Announces Fiscal 2020 Fourth-Quarter, Full-Year Financial Results PR Newswire
Aug-25-20 10:14AM	Lannett's Earnings Outlook Benzinga
Aug-19-20 06:52AM	Lannett To Report Fiscal 2020 Fourth-Quarter, Full-Year Financial Results, Host Conference Call On Wednesday, August 26 PR Newswire
Aug-17-20 04:30PM	Lannett Announces Notice Of Proposed Settlement And Dismissal With Prejudice Of Derivative Action PR Newswire
06:52AM	Lannett Signs Agreement To Be Exclusive Distributor Of Generic Flovent® Diskus® PR Newswire
Aug-03-20 06:53AM	Lannett Announces Launch Of FDA Approved Levothyroxine Tablets PR Newswire +5.21%

Lannett Company, Inc. develops, manufactures, packages, markets, and distributes generic versions of brand pharmaceutical products in the United States. The company offers solid oral and extended release, topical, liquid, nasal, and oral solution finished dosage forms of drugs that address a range of therapeutic areas, as well as ophthalmic, nasal, patch, foam, buccal, sublingual, suspensions, soft gel, injectable, and oral dosages. It also provides its products for various medical indications, such as analgesic, anti-psychosis, cardiovascular, central nervous system, endocrinology, gastrointestinal, infectious disease, migraine, respiratory/allergy/cough/cold, urinary, and others medical indications. The company's primary products include Levothyroxine Sodium tablets, Fluphenazine tablets, Posaconazole DR tablets, Verapamil SR tablets, Methylphenidate CD capsules, Omeprazole capsules, Pantoprazole Sodium DR tablets, Sumatriptan Nasal spray, Metolazone tablets, Amphetamine IR Tablets, Methylphenidate Hydrochloride ER stimulants, as well as cocaine hydrochloride solution. It sells its pharmaceutical products to generic pharmaceutical distributors, drug wholesalers, chain drug retailers, private label distributors, mail-order pharmacies, other pharmaceutical companies, managed care organizations, hospital buying groups, governmental entities, and health maintenance organizations. The company has supply and development agreements with Summit Bioscience LLC, HEC Group of companies, Dexcel Pharma, Elite Pharmaceuticals, RivoPharm, and various other companies. Lannett Company, Inc. was incorporated in 1942 and is headquartered in Trevose, Pennsylvania.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
LEPORE PATRICK G	Director	May 16	Buy	0.54	50,000	27,000	487,145	May 17 04:16 PM
FARBER JEFFREY	Director	Mar 17	Buy	0.81	20,000	16,200	2,152,454	Mar 21 04:26 PM
Israel Samuel H	Chief Legal Officer	Feb 15	Buy	0.81	12,000	9,720	175,453	Feb 15 05:45 PM
Chapman John C	Director	Feb 11	Buy	0.80	12,500	10,000	154,324	Feb 15 05:46 PM
Abt John	Chief Quality and Operations	Feb 10	Buy	0.90	5,000	4,500	128,815	Feb 11 04:31 PM
FARBER JEFFREY	Director	Feb 09	Buy	0.92	10,000	9,200	2,132,454	Feb 10 05:16 PM
LEPORE PATRICK G	Director	Feb 08	Buy	0.88	50,000	44,000	437,145	Feb 10 05:17 PM
KOZLOWSKI JOHN	VP of Finance & CFO	Dec 14	Buy	1.81	4,900	8,869	157,494	Dec 14 04:26 PM
Crew Timothy C	Chief Executive Officer	Dec 13	Buy	1.99	20,000	39,800	584,270	Dec 14 04:25 PM
KOZLOWSKI JOHN	VP of Finance & CFO	Dec 02	Buy	1.68	4,000	6,720	152,594	Dec 02 04:18 PM
LEPORE PATRICK G	Director	Nov 29	Buy	1.71	50,000	85,500	387,145	Nov 30 04:05 PM
FARBER JEFFREY	Director	Nov 17	Buy	1.93	10,000	19,300	2,122,454	Dec 01 04:42 PM
KOZLOWSKI JOHN	VP of Finance & CFO	Nov 16	Buy	2.06	7,000	14,420	148,594	Nov 16 04:13 PM
Rewolinski Melissa	Director	Sep 09	Sale	3.18	25,340	80,581	62,100	Sep 13 04:09 PM
LEPORE PATRICK G	Director	Sep 08	Buy	3.31	20,000	66,200	337,145	Sep 09 04:07 PM
Crew Timothy C	Chief Executive Officer	Jun 14	Buy	5.00	10,000	50,000	411,058	Jun 15 04:29 PM
FARBER JEFFREY	Director	May 28	Buy	4.37	10,000	43,700	1,678,510	Jun 01 04:44 PM

open in yahoo | open in reuters | open in marketwatch | open in google

Upgrade your FINVIZ experience